Arm lymphedema represents a major complication in the patients diagnosed and treated for breast cancer, due to both its high frequency of appearance and to multiple implications on the patient’s quality of life, with few therapy options of low efficiency. The present article has the objective of determining the main factors involved in the occurence of arm lymphedema subsequent to the treatment of breast cancer through a thorough evaluation of the latest research regarding this pathology.